Patrick Mouret

Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial

Ajay K. Kakkar, Benjamin Brenner, Ola E. Dahl et al. · The Lancet · 2008 · 1.1K citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

A Comparison of Recombinant Hirudin with a Low-Molecular-Weight Heparin to Prevent Thromboembolic Complications after Total Hip Replacement

Bengt I. Eriksson, Peter Kälebo, Patrick Mouret et al. · New England Journal of Medicine · 1997 · 371 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement

Giancarlo Agnelli, Alexander T. Cohen, Ola E. Dahl et al. · Thrombosis and Haemostasis · 2003 · 252 citations

Medicine, Orthopaedic Surgery, Surgery +17

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study

Bengt I. Eriksson, Giancarlo Agnelli, Alexander T. Cohen et al. · Journal of Thrombosis and Haemostasis · 2003 · 199 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Rivaroxaban or Enoxaparin in Nonmajor Orthopedic Surgery

Charles Marc Samama, Silvy Laporte, Nadia Rosencher et al. · New England Journal of Medicine · 2020 · 97 citations · Full text

Medicine, Orthopedic Surgery, Surgery +14